1998
DOI: 10.1021/jm970847e
|View full text |Cite
|
Sign up to set email alerts
|

Selective Endothelin A Receptor Antagonists. 4. Discovery and Structure−Activity Relationships of Stilbene Acid and Alcohol Derivatives

Abstract: This publication describes the synthesis and optimization of a novel series of stilbene endothelin antagonists. Analysis of the SAR established for previous papers in this series prompted the design and synthesis of (Z)-4-phenyl-5-(3-benzyloxyphenyl)pent-4-enoic acid 3 which was found to be a moderately active inhibitor of the binding of [125I]ET-1 to ETA receptors with an IC50 of 6 microM. More interestingly, the intermediate compound (E)-2-phenyl-3-(3-benzyloxyphenyl)propenoic acid 5 was equiactive with 3. O… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
10
0

Year Published

1999
1999
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 26 publications
0
10
0
Order By: Relevance
“…Endothelin receptor antagonists are useful therapeutic agents which are being developed for possible indications in congestive heart failure, hypertension, and some other areas. Extensive work in medicinal chemistry has been reported in the literature . Practical syntheses of some compounds in development were also described .…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Endothelin receptor antagonists are useful therapeutic agents which are being developed for possible indications in congestive heart failure, hypertension, and some other areas. Extensive work in medicinal chemistry has been reported in the literature . Practical syntheses of some compounds in development were also described .…”
Section: Introductionmentioning
confidence: 99%
“…Practical syntheses of some compounds in development were also described . In this paper, we report a practical, concise synthesis of one of the endothelin receptor antagonists which is under development jointly by Merck and Banyu 1a. The objective of this work was to develop an efficient, safe, cost-effective, and environmentally friendly synthesis of this compound suitable for scale-up so that kilogram quantities of this drug candidate could be made via this chemistry for safety assessment and clinical studies.…”
Section: Introductionmentioning
confidence: 99%
“…This interaction would give a compact molecular arrangement of the analogue and would jut out the Glu 10 carboxylic function that appears to be essential for ET A , as suggested by the complete loss of activity following its amidation (compound 19). Also, accordingly, previous studies reported that specific ET A receptor antagonists require, at the receptor level, an interaction with a putative cationic site surrounded by a hydrophobic environment (Astles et al, 1998a, b). Thus, the negative charge of Glu 10 would probably interact directly with this putative cationic site found on ET A receptors.…”
mentioning
confidence: 93%
“…2,[5][6][7][15][16][17] In addition, many of the existing synthetic methods suffer from certain limitations with respect to yield, reaction conditions and toxicity. In particular, the formylations of 6, performed under strongly basic conditions, usually lead to 1 in rather low yields.…”
mentioning
confidence: 99%